Financials
Value Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 27 M29 M35 M — Research & development ——— — Operating income -176 M-254 M253 M — Non-Operating Income, Total -47 M-13 M-10 M — Interest expense, net of interest capitalized —3 M— — Non-Operating Income, excl. Interest Expenses -46 M-13 M-10 M — Unusual income/expense -1 M0— — Pretax income -223 M-267 M243 M — Equity in earnings ——— — Taxes -26 M-21 M28 M — Non-controlling/minority interest -120 M-143 M118 M — After tax other income/expense ——— — Net income before discontinued operations -77 M-103 M97 M — Discontinued operations ——— — Net income -77 M-103 M97 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -78 M-103 M97 M — Basic earnings per share (Basic EPS) -0.52-0.730.54 — Diluted earnings per share (Diluted EPS) -0.52-0.730.53 — Average basic shares outstanding 148.88 M142.53 M181.3 M — Diluted shares outstanding 148.93 M142.53 M181.42 M — EBITDA 6 M-20 M459 M — EBIT -176 M-254 M253 M — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 182 M234 M206 M —